Mitochondrial membrane potential change induced by Hoechst 33342 in myelogenous leukemia cell line HL-60

Annals of Clinical and Laboratory Science

Volumn 34, Issue 4, 2004, Pages 458-466

  Chen, Jenn C ^a   Zhang, Xinbo ^a   Singleton, Timothy P ^a   Kiechle, Frederick L ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

Apoptosis; Hoechst 33342; Mitochondrial membrane potential; Myelogenous leukemia

Indexed keywords

3,3' DIHEXYLOXACARBOCYANINE; 5,5',6,6' TETRACHLORO 1,1',3,3' TETRAETHYLBENZIMDAZOLYLCARBOCYANINE IODIDE; ACRIDINE DERIVATIVE; CARBONYL CYANIDE CHLOROPHENYLHYDRAZONE; FLUOROCHROME; HOE 33342; IONOPHORE; NONYL ACRIDINE ORANGE; PROPIDIUM IODIDE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL STRAIN HL 60; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEPOLARIZATION; DOSE RESPONSE; DRUG EFFECT; FLUORESCENCE; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MASS; MEMBRANE POTENTIAL; MITOCHONDRIAL MASS; MITOCHONDRIAL MEMBRANE; MYELOID LEUKEMIA; PRIORITY JOURNAL;

APOPTOSIS; BENZIMIDAZOLES; BISBENZIMIDE; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; FLUORESCENT DYES; HL-60 CELLS; HUMANS; INTRACELLULAR MEMBRANES; LEUKEMIA, PROMYELOCYTIC, ACUTE; MEMBRANE POTENTIALS; MITOCHONDRIA;

EID: 11044236739     PISSN: 00917370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Kroemer G, Zamzami N, Susin SA. Mitochondrial control of apoptosis. Immunol Today 1997;18:44-51.
2. Bernardi P, Petronilli V, Di Lisa F, Forte M. A mitochondrial perspective on cell death. Trends Biochem Sci 2001;26:112-117.
3. Chen LB. Mitochondrial membrane potential in living cells. Annu Rev Cell Biol 1988;4:155-181.
4. Chen Q, Takeyama N, Brady G, Watson AJ, Dive C. Blood cells with reduced mitochondrial membrane potential and cytosolic cytochrome C can survive and maintain clonogenicity given appropriate signals to suppress apoptosis. Blood 1998;92:4545-4553.
5. Maftah A, Petit JM, Ratinaud MH, Julien R. 10-N nonyl-acridine orange: A fluorescent probe which stains mitochondria independently of their energetic state. Biochem Biophys Res Commun 1989;164:185-190.
6. Zamzami N, Marchetti P, Castedo M, Zanin C, Vayssiere JL, Petit PX, Kroemer G. Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. J Exp Med 1995;181:1661-1672.
7. Cossarizza A, Baccarani-Contri M, Kalashnikova G, Franceschi C. A new method for the cytofluorimetric analysis of mitochondrial membrane potential using the J-aggregate forming lipophiliccation 5,5′,6,6′- tetrachloro-1,1′,3,3′-tetraethylbenzimidazolcarbocyanine iodide (JC-1). Biochem Biophys Res Commun 1993;197:40-45.
8. Smiley ST, Reers M, Mottola-Hartshorn C, Lin M, Chen A, Smith TW, Steele GD, Chen LB. Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate-forming lipophilic cation JC-1. PNAS USA 1991;88:3671-3675.
9. Green D, Kroemer G. The central executioners of apoptosis: Caspases or mitochondria? Trends Cell Biol 1998;8:267-271.
10. Castedo M, Hirsch T, Susin SA, Zamzami N, Marchetti P, Macho A, Kroemer G. Sequential acquisition of mitochondrial and plasma membrane alterations during early lymphocyte apoptosis. J Immunol 1996;157:512-521.
11. Kiechle FL, Zhang X. Apoptosis: biochemical aspects and clinical implications. Clin Chim Acta 2002;326:27-45.
12. Ricci JE, Gottlieb RA, Green DR. Caspase-mediated loss of mitochondrial function and generation of reactive oxygen species during apoptosis. J Cell Biol 2003;160:65-75.
13. Huigsloot M, Tijdens IB, Mulder GJ, van de Water B. Differential regulation of doxorubicin-induced mitochondrial dysfunction and apoptosis by bcl-2 in mammary adenocarcinoma (MTLn3) cells. J Biol Chem 2002;277:35869-35879.
14. Zhang X, Chen J, Davis B, Kiechle F. Hoechst 33342 induces apoptosis in HL-60 cells and inhibits topoisomerase I in vivo. Arch Pathol Lab Med 1999;123:921-927.
15. Zhang X, Kiechle FL. Hoechst 33342 induces apoptosis and alters TATA box binding protein/DNA complexes in nuclei from BC3H-1 myocytes. Biochem Biophys Res Commun 1998;248:18-21.
16. Zhang X, Kiechle FL. Hoechst 33342-induced apoptosis in BC3H-1 myocytes. Ann Clin Lab Sci 1997;27:260-275.
17. Kluza J, Lansiaux A, Wattez N, Mahieu C, Osheroff N, Bailly C. Apoptotic response of HL-60 human leukemia cells to the antitumor drug TAS-103. Cancer Res 2000;60:4077-4084.
18. Mancini M, Sedghinasab M, Knowlton K, Tam A, Hockenbery D, Anderson BO. Flow cyto-metric measurement of mitochondrial mass and function: a novel method for assessing chemoresistance. Ann Surg Oncol 1998;5:287-295.
19. 6(3) or rhodamine 123, is a reliable fluorescent probe to assess delta psi changes in intact cells: implications for studies on mitochondrial functionality during apop-tosis. FEBS Lett 1997;411:77-82.
20. Minamikawa T, Williams DA, Bowser DN, Nagley P. Mitochondrial permeability transition and swelling can occur reversibly without inducing cell death in intact human cells. Exp Cell Res 1999;246:26-37.
21. Petit PX, Lecoeur H, Zorn E, Dauguet C, Mignotte B, Gougeon ML. Alterations in mitochondrial structure and function are early events of dexamethasone-induced thymocyte apoptosis. J Cell Biol 1995;130:157-167.
22. Mignotte B, Vayssiere JL. Mitochondria and apoptosis. Eur J Biochem 1998;252:1-15.
23. Septinus M, Berthold T, Naujok A, Zimmermann HW. Hydrophobic acridine dyes for fluorescent staining of mitochondria in living cells. 3. Specific accumulation of the fluorescent dye NAO on the mitochondrial membranes in HELA cells by hydrophobic interaction. Depression of respiratory activity, changes in the ultrastructure of mitochondria due to NAO. Increase of fluorescence in vital stained mito-chondria in situ by irradiation]. Histochemistry 1985;82:51-66.
24. Garcia Fernandez M, Troiano L, Moretti L, Pedrazzi J, Salvioli S, Castilla-Cortazar I, Cossarizza A. Changes in intramitochondrial cardiolipin distribution in apoptosis-resistant HCW-2 cells, derived from the human promyelcytic leukemia HL-60. FEBS Lett 2000;478:290-294.
25. Keij JF, Bell-Prince C, Steinkamp JA. Staining of mitochondrial membranes with 10-nonyl acridine orange, MitoFluor Green, and Mitotracker Green is affected by mitochondrial membrane potential altering drugs. Cytometry 2000;39:203-210.
26. Reipert S, Berry J, Hughes MF, Hickman JA, Allen TD. Changes of mitochondrial mass in the hemopoietic stem cell line FDCP-mix after treatment with etoposide: a correlative study by multiparameter flow cytometry and confocal and electron microscopy. Exp Cell Res 1995;221:281-288.
27. Salvioli S, Dobrucki J, Moretti L, Troiano L, Fernandez MG, Pinti M, Pedrazzi J, Franceschi C, Cossarizza A. Mitochondrial heterogeneity during staurosporine-induced apoptosis in HL60 cells: analysis at the single cell and single organelle level. Cytometry 2000;40:189-197.
28. Krysko DV, Roels F, Leybaert L, D'Herde K. Mitochondrial transmembrane potential changes support the concept of mitochondrial heterogeneity during apoptosis. J Histochem Cytochem 2001;49:1277-1284.
29. Armstrong JS, Steinauer KK, French J, Killoran PL, Walleczek J, Kochanski J, Knox SJ. Bcl-2 inhibits apoptosis induced by mitochondrial uncoupling but does not prevent mitochondrial transmembrane depolarization. Exp Cell Res 2001;262:170-179.
30. Finucane DM, Waterhouse NJ, Amarante-Mendes GP, Cotter TG, Green DR. Collapse of the inner mitochondrial transmembrane potential is not required for apoptosis of HL60 cells. Exp Cell Res 1999;251:166-174.
31. Smith PJ, Bell SM, Dee A, Sykes H. Involvement of DNA topoisomerase II in the selective resistance of a mammalian cell mutant to DNA minor groove ligands: ligand-induced DNA-protein crosslinking and responses to topoisomerase poisons. Carcinogenesis 1990;11:659-665.
32. Chen AY, Scruggs PB, Geng L, Rothenberg ML, Hallahan DE. P53 and p21 are major cellular determinants for DNA topoisomerase I-mediated radiation sensitization in mammalian cells. Ann NY Acad Sci 2000;922:298-300.